Connect your AI

Vivani Medical VANI Investing Cash Flow

Investing Cash Flow at other companies

Eli LillyLLY

-$3.92B-16.8%

AmgenAMGN

-$716M-60.2%

AltimmuneALT

-$3.69M+27.7%

Viking TherapeuticsVKTX

$54.19M-14.3%

Wave Life SciencesWVE

-$438K-165%

Prime MedicinePRME

$43.39M+191%

Other financials

Income statement

Revenue-—

Gross profit$130.0K—

Operating income-$6.8M-4.0%

Net income-$6.8M-7.6%

EPS (diluted)-$0.08+27.3%

Balance sheet

Cash & equivalents$19.0M+57.7%

Total debt$18.3M-3.5%

Total equity$19.1M+64.2%

Total assets$42.4M+19.5%

Cash flow

Operating cash flow-$6.2M-20.0%

CapEx$3.0K-40.0%

Free cash flow-$6.2M-19.9%

Valuation

Market cap$106.93M+40.0%

Enterprise value$106.17M+19.3%

Profitability

Gross margin36.3%—

Operating margin-1,004.9%—

Net margin-994.1%—

FCF margin-832.3%—

Returns & leverage

Return on equity-176.4%+175pp

Debt / equity1×-0.7×

Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Vivani Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Vivani Medical's investing cash flow?: Vivani Medical (VANI) reported investing cash flow of -$3K in Q1 2026.
How has Vivani Medical's investing cash flow changed year-over-year?: Vivani Medical's investing cash flow increased by 40.0% year-over-year, from -$5K to -$3K.
What is the long-term trend for Vivani Medical's investing cash flow?: Over 3 years (2022 to 2025), Vivani Medical's investing cash flow has grown at a 51.4% compound annual growth rate (CAGR), from -$338K to -$1.17M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.